Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NOrdic-Baltic Randomized Registry Study for Long-term Clinical Evaluation of Adjunction of PCI to Optimal Medical Therapy in Chronic Total Coronary Occlusion

NCT03392415 is registered in ClinicalTrials.gov with Leif Thuesen as lead sponsor.

NCT NCT03392415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NOrdic-Baltic Randomized Registry Study for Long-term Clinical Evaluation of Adjunction of PCI to Optimal Medical Therapy in Chronic Total Coronary Occlusion
Lead sponsor
Leif Thuesen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 1, 2018
Completion date
July 1, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, chronic total occlusion of coronary artery, heart failure